Chengsen Chai

Dual-aptamer-engineered M1 macrophage with enhanced specific targeting and checkpoint blocking for solid-tumor immunotherapy

Husun Qian, Yixin Fu, Minkang Guo et al. · Molecular Therapy · 2022 · 29 citations · Full text

Life Sciences, Immunology, Oncology +17

TROP2 is highly expressed in triple-negative breast cancer CTCs and is a potential marker for epithelial mesenchymal CTCs

Qingyu Liao, Ruiming Zhang, Zuli Ou et al. · Molecular Therapy Oncology · 2024 · 28 citations · Full text

Medicine, Bioinformatics, Oncology +17

The miR-345-3p/PPP2CA signaling axis promotes proliferation and invasion of breast cancer cells

Qian Zeng, Fangfang Jin, Husun Qian et al. · Carcinogenesis · 2021 · 19 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

GNPNAT1 is a potential biomarker correlated with immune infiltration and immunotherapy outcome in breast cancer

Renjie Yuan, Yulu Zhang, Yange Wang et al. · Frontiers in Immunology · 2023 · 13 citations · Full text

Medicine, Molecular Biology, Oncology +17

PDK1‐stabilized LncRNA SPRY4‐IT1 promotes breast cancer progression via activating NF‐κB signaling pathway

Yulu Zhang, Hongling Chen, Renjie Yuan et al. · Molecular Carcinogenesis · 2023 · 11 citations · Full text

Life Sciences, Molecular Biology, Oncology +15